Disc Medicine, Inc.
321 Arsenal Street, Suite 101
Watertown, MA 02472
January 20, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance – Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Re: |
Disc Medicine, Inc. Registration Statement on Form S-3 File No. 333-269272 Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Disc Medicine, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269272) (the “Registration Statement”), so that it may become effective at 4:01 pm Eastern time on January 24, 2023, or as soon thereafter as practicable.
| Very truly yours,
DISC MEDICINE, INC. | ||
| By: |
/s/ John Quisel | |
| Name: John Quisel, J.D., Ph.D. Title: Chief Executive Officer | ||
Cc: William Collins, Goodwin Procter LLP